Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chungen Pan

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Plos Currents|March 2, 2012
E14-F55 combination in M2 protein: a putative molecular determinant responsible for swine-origin influenza A virus transmission in humansChungen Pan, Shibo Jiang
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 9, 2010
HIV-1 gp41 fusion intermediate: a target for HIV therapeuticsChungen Pan, Shuwen Liu, Shibo Jiang
AIDS (London, England)|February 27, 2009
Synergistic efficacy of combination of enfuvirtide and sifuvirtide, the first- and next-generation HIV-fusion inhibitorsChungen Pan, Hong Lu, Zhi Qi, et al.
The Journal of Biological Chemistry|June 22, 2011
A novel chimeric protein-based HIV-1 fusion inhibitor targeting gp41 glycoprotein with high potency and stabilityChungen Pan, Lifeng Cai, Hong Lu, et al.
Journal of Virology|June 5, 2009
Combinations of the first and next generations of human immunodeficiency virus (HIV) fusion inhibitors exhibit a highly potent synergistic effect against enfuvirtide- sensitive and -resistant HIV type 1 strainsChungen Pan, Lifeng Cai, Hong Lu, et al.
Biochemical and Biophysical Research Communications|May 26, 2009
High genetic and antigenic similarity between a swine H3N2 influenza A virus and a prior human influenza vaccine virus: a possible immune pressure-driven cross-species transmissionChungen Pan, Guiping Wang, Ming Liao, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|July 8, 2010
Fab crystallization and preliminary X-ray analysis of NC-1, an anti-HIV-1 antibody that recognizes the six-helix bundle core of gp41Lei Jin, Chungen Pan, Zhi Qi, et al.
Microbes and Infection|February 5, 2020
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, ChinaFei Yu, Lanying Du, David M Ojcius, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 17, 2011
Interactions between different generation HIV-1 fusion inhibitors and the putative mechanism underlying the synergistic anti-HIV-1 effect resulting from their combinationLifeng Cai, Chungen Pan, Liang Xu, et al.
Retrovirology|December 11, 2012
A bivalent recombinant protein inactivates HIV-1 by targeting the gp41 prehairpin fusion intermediate induced by CD4 D1D2 domainsLu Lu, Chungen Pan, Yuan Li, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Plos Currents|March 2, 2012
E14-F55 combination in M2 protein: a putative molecular determinant responsible for swine-origin influenza A virus transmission in humansChungen Pan, Shibo Jiang
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 9, 2010
HIV-1 gp41 fusion intermediate: a target for HIV therapeuticsChungen Pan, Shuwen Liu, Shibo Jiang
AIDS (London, England)|February 27, 2009
Synergistic efficacy of combination of enfuvirtide and sifuvirtide, the first- and next-generation HIV-fusion inhibitorsChungen Pan, Hong Lu, Zhi Qi, et al.
The Journal of Biological Chemistry|June 22, 2011
A novel chimeric protein-based HIV-1 fusion inhibitor targeting gp41 glycoprotein with high potency and stabilityChungen Pan, Lifeng Cai, Hong Lu, et al.
Journal of Virology|June 5, 2009
Combinations of the first and next generations of human immunodeficiency virus (HIV) fusion inhibitors exhibit a highly potent synergistic effect against enfuvirtide- sensitive and -resistant HIV type 1 strainsChungen Pan, Lifeng Cai, Hong Lu, et al.
Biochemical and Biophysical Research Communications|May 26, 2009
High genetic and antigenic similarity between a swine H3N2 influenza A virus and a prior human influenza vaccine virus: a possible immune pressure-driven cross-species transmissionChungen Pan, Guiping Wang, Ming Liao, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|July 8, 2010
Fab crystallization and preliminary X-ray analysis of NC-1, an anti-HIV-1 antibody that recognizes the six-helix bundle core of gp41Lei Jin, Chungen Pan, Zhi Qi, et al.
Microbes and Infection|February 5, 2020
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, ChinaFei Yu, Lanying Du, David M Ojcius, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 17, 2011
Interactions between different generation HIV-1 fusion inhibitors and the putative mechanism underlying the synergistic anti-HIV-1 effect resulting from their combinationLifeng Cai, Chungen Pan, Liang Xu, et al.
Retrovirology|December 11, 2012
A bivalent recombinant protein inactivates HIV-1 by targeting the gp41 prehairpin fusion intermediate induced by CD4 D1D2 domainsLu Lu, Chungen Pan, Yuan Li, et al.
Pageof 4